Paolo Miotto

24PUBLICATIONS
98CO-AUTHORS
Disease surveillanceMicrobial geneticsMedical biotechnology diagnostics (incl. biosensors)Medical infection agents (incl. prions)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 26, 2026
Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.

|Jul 20, 2026
Mycobacterium tuberculosis diversity and macrophage heterogeneity dictate phagosomal acidification.

|Apr 27, 2026
Diagnostic Assays for TB Disease and Drug Resistance Detection-Advances and Latest WHO Recommendations.

|Dec 12, 2025
Clinical evaluation of a commercial culture-free targeted next-generation sequencing test for diagnosis of drug-resistant tuberculosis.

Paolo Miotto, Rebecca E Colman, Andrea M Cabibbe

|Sep 22, 2025
In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis.

Praharshinie Rupasinghe, Nabila Ismail, Wim Mulders

|Mar 03, 2025
Multivariable regression models improve accuracy and sensitive grading of antibiotic resistance mutations in Mycobacterium tuberculosis.

Sanjana G Kulkarni, Sacha Laurent, Paolo Miotto

Pageof 4

Frequent Collaborators

15 joint publications

Daniela Maria Cirillo

9 joint publications

Claudio Umberto Köser

5 joint publications

Maha R Farhat

5 joint publications

Timothy C Rodwell